About the journal
Clinical and Translational Discovery is an open-access journal published by Wiley in Australia, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,040 EUR. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2768-0622
- Country
- Australia
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,040 EUR
- Articles in DOAJ
- 474
- Declared review time
- 10 weeks
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/27680622
Index listings
- DOAJ · 2022-05-18
- Indexing
- DOAJ
- APC
- 2,040 EUR
- Declared review time (DOAJ)
- 10 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
474
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
10weeks
Works in OpenAlex
503
Last recorded publication year
2026
h-index
16
i10-index
32
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2022-05-18
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 88%
- ORCID iDs in current deposits
- 62%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- CTDClinical & translational discovery
- Source type
- journal
- NLM unique ID (PubMed)
- 9918266190206676
- Society affiliations
- The Shanghai Institute of Clinical Bioinformatics (SICB)
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- RNA modifications and cancer
- RNA modifications and cancer
Show all subjects (50)
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Immunotherapy and Biomarkers
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Ferroptosis and cancer prognosis
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Immune cells in cancer
- Immune cells in cancer
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Educational Robotics and Engineering
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Peptidase Inhibition and Analysis
- Educational Robotics and Engineering
- Peptidase Inhibition and Analysis
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Cancer, Hypoxia, and Metabolism
- Ubiquitin and proteasome pathways
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Ubiquitin and proteasome pathways
- Medical and Biological Sciences
- Medical and Biological Sciences
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Pancreatic and Hepatic Oncology Research
- SARS-CoV-2 and COVID-19 Research
- Mitochondrial Function and Pathology
- SARS-CoV-2 and COVID-19 Research
Keywords (DOAJ)
- gene therapy
- transcriptional networks
- translational medicine
- diagnosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ